awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38180744-0C710D4F-F6EA-4425-8293-76D4FE6E7E58
Q38180744-0C710D4F-F6EA-4425-8293-76D4FE6E7E58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38180744-0C710D4F-F6EA-4425-8293-76D4FE6E7E58
Management of metastatic kidney cancer in the era of personalized medicine.
P2860
Q38180744-0C710D4F-F6EA-4425-8293-76D4FE6E7E58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38180744-0C710D4F-F6EA-4425-8293-76D4FE6E7E58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e9d6c2ad3589850fd1148a59587466510106322
P2860
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.